explore -WSS

explore

author：explore 2025-10-03 00:40:56 - browse：69

Adobe

Medicare announced on Saturday that it will make advance payments available to physician groups, hospitals, and other health care facilities as part of its response to the February 21 Change Healthcare cyberattack.

The payments are meant to fund providers that aren’t able to submit claims to Medicare because of the disruption to Change’s data network and have exhausted all other potential avenues of funding. Medicare will advance up to 30 days of payment, based on the average monthly amount a provider received from Medicare from August 1 to October 31, 2023. The providers are expected to repay the money 90 days after receiving the payment, with interest beginning to accrue 30 days after that.

“We welcome today’s announcement and will continue to work with policymakers as the impacts from the cyberattack persist,” the American Hospital Association said in a statement after the announcement.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Biotech startup Celsius cuts 75% of staff ahead of first trial start

hotspot

WSS

It costs an awful lot of money to give away a kidney

FDA approves Sage Therapeutics’ rapid

New research casts further doubt on a common procedure used with IVF

Group behind ProMed defends move to subscription

When waiting feels immoral: Empathy in the emergency department

Group behind ProMed defends move to subscription

hotspot

explore

explore

23andMe had bad news about my health. I wish a person had delivered it

Heart disease in astronauts blamed on cosmic radiation

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

N.Y. state detects polio case, first in the U.S. since 2013

George Santos makes 1st court appearance after pleading not guilty to 13 counts

'Null' research findings aren't empty of meaning. Let's publish them

Psychedelics group wrestles with new pharma identity

What to know about OceanGate, the company behind the missing Titanic submersible

Trump demands the U.S. pay no more for drugs than other countries … again

Biotech startup Celsius cuts 75% of staff ahead of first trial start

focus

Palantir health business leans on meeting customers’ needs

Group behind ProMed defends move to subscription

It's time to get medical device identifiers over the finish line

Why 40% Americans with Parkinson’s don’t see a neurologist

FDA scientists endorse Pfizer/BioNTech Covid

FDA scientists endorse Pfizer/BioNTech Covid

focus

knowledge

hotspot

knowledge